A heavy investment in Valeant Pharmaceuticals that caused a loss of $393 million led former DST Systems employees to sue, claiming that the company breached its fiduciary duty by allowing its employee profit-sharing plan to become too concentrated.
A heavy investment in Valeant Pharmaceuticals that caused a loss of $393 million led former DST Systems employees to sue, claiming that the company breached its fiduciary duty by allowing its employee profit-sharing plan to become too concentrated.